Venture Leaders Medtech 2025: Ten Swiss startups selected for US expansion
Ten promising startups have been named to the Swiss National Medtech Team 2025 and will travel to Boston from September 28th to October 3rd to pitch to investors, expand their network, and meet industry leaders. The Venture Leaders Medtech program is organized by Venturelab, with the support of EPFL, ETH Zurich, Hansjörg Wyss, Helbling Technik, Health Innovation Hub Aargau, Kellerhals Carrard, Canton de Vaud, and Vischer.
Since 2006, Venturelab has been selecting the Swiss National Startup Team. Through its Venture Leaders roadshows, entrepreneurs engage with top experts, investors, and potential customers in leading global tech hubs, including Silicon Valley, Boston, Asia, Barcelona, Munich, and London.Following a competitive selection process that reviewed over 70 applications, a jury of investors and industry experts chose ten startups to join the upcoming roadshow in Boston—one of the world’s leading hubs for life sciences and healthcare innovation. The week-long program will give participants the opportunity to connect with industry leaders, potential partners, and investors, supporting their efforts to expand into the US market.
The selected Swiss medtech startups are capturing global attention — and for good reason. They are tackling a range of challenges, from smart implants and AI-powered diagnostics to neonatal nutrition and non-invasive monitoring. “These innovations aren’t just impressive — they have the potential to transform how medtech is delivered worldwide,” said Stefan Steiner, Co-Managing Director of Venturelab.
This year's Venture Leaders Technology participants join an impressive group of alumni, including Lunaphore Technologies (acquired by Bio-Techne), Virtamed, Credentis (acquired by vVardis), Stimit (acquired by Dräger), CUTISS, Distalmotion, MindMaze, Positrigo, and Volumina Medical. “The organization of the program was exceptional, and the quality of the meetings exceeded all my expectations,” highlighted Pablo Lara, Co-founder of OncoSwab, past Venture Leader Medtech 2024. “I was so impressed that I even changed my flight to extend my stay and continue benefiting from this enriching environment. I cannot recommend this program highly enough."
Join the online introduction and pitch session of Venture Leaders Medtech 2025 on August 19, 2025 — an opportunity to discover next-level developments in medical technology. Follow the Venture Leaders Medtech roadshow on social media using the hashtag #VLeadersMedtech or on www.venture-leaders.ch/medtech from Septer 28th to October 3rd, 2025.
The Venture Leaders Medtech 2025 program is organized by Venturelab with the support of EPFL, ETH Zurich, Hansjörg Wyss, Helbling Technik, Health Innovation Hub Aargau, Kellerhals Carrard, Canton de Vaud, and Vischer.
About Venture Leaders
The Venture Leaders – the members of the Swiss National Startup Team – have a clear goal: envisioning themselves as global players, they want to take the first step towards their global expansion. Venturelab has over 20 years of experience bringing Switzerland’s best entrepreneurs to the heart of the global technology hubs: Silicon Valley, Boston, China, London, Barcelona, and Munich. Companies founded by the 600 Venture Leaders alumni have created more than 12,990 jobs, 73 exits, and raised more than CHF 9,2 billion in investment capital. For more information, visit www.venture-leaders.ch, and discover all the alumni here.
DISCOVER THE TEN VENTURE LEADERS MEDTECH 2025:
Augury Medical GmbH: Improving patient care with novel heartbeat visualizations.
We aim to improve the safety of cardiovascular disease treatment by overcoming limitations in state-of-the-art cardiac imaging technology, which is currently limited by invasiveness, lack of 3D capabi... Read more
Babylat AG: On-site human milk fortifiers for preterm neonates in NICUs
Very low birth weight (VLBW) preterm infants (<1.5 kg) require up to four times more protein and energy than human milk alone provides. Without adequate fortification, they face poor weight gain and l... Read more
Clee Medical SA: Transforming brain surgery via real-time vision and control.
Brain surgery requires precise access to deep brain targets without damaging surrounding tissue. Yet most surgeries rely solely on static pre-operative imaging. Clee Medical is developing a ultra-high... Read more
dEEGtal Insight SA: AI-powered epilepsy diagnosis software for rapid results
Epilepsy diagnosis is difficult: after a first seizure, 70–80% of electroencephalograms appear normal, leading to high misdiagnosis rates and delayed treatment. Current methods lack sensitivity and fa... Read more
DigeHealth AG: 24/7 non-invasive solution for bowel obstruction prevention.
There are more than 8M abdominal surgeries per year. 1 patient over 4 will suffer from a bowel obstruction. Additionally, 60% of Crohn disease patient will suffer from bowel obstructions. Without time... Read more
Hemetron AG: Better treatments through accurate mobile health tests.
Hemetron is transforming chronic disease management with precise, at-home blood testing. Millions of patients with inflammatory rheumatic diseases lack effective monitoring, resulting in poor treatmen... Read more
Inteeth SA: Aestetic and Patient-Friendly Orthodontics
Braces and aligners help straighten teeth, but they come with trade-offs: metal braces are visible, lingual braces are costly and uncomfortable, and clear aligners must be removed constantly. InTeeth ... Read more
NX-Spine AG: Platform technology for bone reinforcement.
The Immediate Stabilization System (ISS) will first be used in spinal fusion. Annually, tens of thousands of patients experience complications due to screw loosening leading to pain and increased cost... Read more
OrthoSens SA: Making implants talk
Orthopedic surgeries still rely on static X-rays and sporadic follow-ups, providing minimal real-time feedback. Surgeons often depend on subjective patient reports, risking delayed interventions, reop... Read more
Scanvio Medical AG: AI-assisted gynecologic ultrasound diagnostics.
Endometriosis affects 10% of women of reproductive age, yet diagnosis is often delayed by 812 years due to reliance on invasive laparoscopy or rare ultrasound experts. Scanvio is developing AI-powere... Read more
Related articles
PaceLocator: The Venture Leader Medtech revolutionizing cardiac care with real-time, 3D heart visualization
read more
Inteeth: The Venture Leader Medtech transforming smiles with patient-friendly, aesthetic orthodontics
read more
Hemetron: The Venture Leader Medtech enabling better treatments through accurate mobile health tests
read more
Clee Medical: The Venture Leader Medtech transforming brain surgery via real-time vision and control
read more
Venture Leaders Medtech 2025 kick-off their Boston roadshow
read more
dEEGtal Insight: The Venture Leader Medtech improving epilepsy diagnosis
read more